LISATA THERAP.INC.DL-001 (8NE) — Net Asset Quality Index
LISATA THERAP.INC.DL-001 (8NE) has a Net Asset Quality Index of 82.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €17.74 Million minus total liabilities of €3.14 Million yields net assets of €14.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. See LISATA THERAP.INC.DL-001 liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
LISATA THERAP.INC.DL-001 Net Asset Quality Index Over Time (2021–2025)
This chart shows how LISATA THERAP.INC.DL-001's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 82.3%, representing net assets of €14.60 Million against total assets of €17.74 Million EUR. Explore LISATA THERAP.INC.DL-001 (8NE) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for LISATA THERAP.INC.DL-001 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for LISATA THERAP.INC.DL-001 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of LISATA THERAP.INC.DL-001.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.3% | €14.60 Million | €17.74 Million | €3.14 Million | ▼ -1.5 pp |
| 2024 | 83.8% | €29.32 Million | €35.00 Million | €5.68 Million | ▼ -3.8 pp |
| 2023 | 87.6% | €47.89 Million | €54.69 Million | €6.80 Million | ▼ -3.2 pp |
| 2022 | 90.8% | €66.32 Million | €73.03 Million | €6.71 Million | ▼ -4.0 pp |
| 2021 | 94.8% | €92.00 Million | €97.01 Million | €5.01 Million | — |